/mssi/taxonomy/term/1021/all en /mssi/channels/news/d2r-announces-new-round-funding-investing-15-million-advance-research-rna-therapeutics-and-support-362236 <p><strong>Montreal – December 19, 2024</strong> – The D2R (DNA to RNA) Initiative is proud to announce the recipients of its latest round of funding, awarding a total of $1.5 million to four principal investigators and five ����SM���� Centres and Institutes. These awards are designed at advancing research in RNA therapeutics by facilitating industry collaboration and supporting the next generation of scientific leaders as well as research Centres and Institutes.</p> Thu, 19 Dec 2024 14:21:58 +0000 admin 8513 at /mssi /mssi/channels/news/open-solution-improving-research-reproducibility-362210 <h2><b>Academic and industry scientists collaborate on a new method to characterize research antibodies</b></h2> Wed, 18 Dec 2024 16:12:19 +0000 admin 8512 at /mssi /mssi/channels/news/cqdm-partners-d2r-enhance-collaborations-among-researchers-and-industry-rna-research-361502 <p><b>Montréal, November 28th</b> – CQDM is proud to announce a strategic partnership with the D2R (DNA to RNA) Initiative at ����SM����, aimed at funding translational research projects carried out through collaborations between researchers and industry. This alliance seeks to support and accelerate the development and commercialization of innovative RNA-based therapies. It aims to provide patients with safer and more effective therapeutic options, particularly for treating cancer, rare diseases, and preventing various infectious diseases.</p> Thu, 28 Nov 2024 14:06:34 +0000 admin 8464 at /mssi /mssi/channels/news/event-workshop-precision-health-and-medicine-january-9-2025-361379 <h3>First Hybrid Workshop on Precision Health and Medicine</h3> <p><em><strong>Synergizing our strengths in new technologies in omics, digital sciences, and translational medicine to advance patient care.</strong></em></p> <p>This event is organized in partnership between University of Bern and ����SM����. This partnership between the universities aims to synergistically harness the power of new technologies in omics, digital sciences, and translational medicine to advance patient care.</p> <p><strong>Event details: </strong></p> Mon, 25 Nov 2024 18:16:42 +0000 admin 8459 at /mssi /mssi/channels/event/mssi-x-xprize-transdisciplinary-symposium-creating-societal-change-361361 <p>On February 3rd, 2025, ����SM���� and <a href="https://www.xprize.org/">the XPRIZE</a> will host a symposium at ����SM���� in Montreal, Canada, celebrating ����SM���� joining the XPRIZE’s Higher Education Network.</p> Fri, 22 Nov 2024 21:25:47 +0000 phuong.hoang3@mcgill.ca 8458 at /mssi /mssi/channels/event/anthropocene-human-epoch-screening-director-jennifer-baichwal-361297 <div><span>A cinematic meditation on humanity’s massive reengineering of the planet, ANTHROPOCENE: The Human Epoch is a four years in the making feature documentary film from the multiple-award winning team of Jennifer Baichwal, Nicholas de Pencier a</span></div> Tue, 19 Nov 2024 20:08:42 +0000 phuong.hoang3@mcgill.ca 8453 at /mssi /mssi/channels/news/open-science-project-funded-15m-361131 <h2><b>YCharOS antibody characterization platform addresses the “reproducibility crisis” in research</b></h2> <p>An innovative research project led by researchers at The Neuro has been awarded $1.5M by the Government of Quebec through CQDM.</p> <p>YCharOS is an innovative platform led by neuroscientists Peter McPherson and Carl Laflamme that validates antibody reagents for human proteins.</p> Tue, 12 Nov 2024 16:51:24 +0000 admin 8452 at /mssi /mssi/channels/news/event-antisense-oligonucleotide-therapy-individual-kif1a-associated-neurological-disorder-november-361123 <p>Dear Colleagues,</p> <p>Please see the next Medical Genetics Grand Rounds scheduled talk below:</p> Tue, 12 Nov 2024 14:30:50 +0000 admin 8449 at /mssi /mssi/channels/news/home-neurological-disorder-diagnosis-project-receives-major-funding-361075 <h2><b>$1M grant from The Weston Family Foundation will pave the way for earlier intervention in REM sleep behaviour disorder and Parkinson’s disease</b></h2> <p>REM sleep behaviour disorder (RBD) is an often debilitating condition that causes people to act out in their sleep, sometimes violently. What’s worse, people with the disorder often go on to develop Parkinson’s disease.</p> Fri, 08 Nov 2024 18:24:33 +0000 admin 8445 at /mssi /mssi/channels/news/can-hopeful-moments-lead-hopeful-futures-357900 <h2 style="text-align:center">Can hopeful moments lead to hopeful futures?</h2> <p style="text-align:center">By Daphne Chalmers (����SM����, Education), Julia Freeman (����SM����, Bieler School of Environment), Diane Dechief (����SM����, Office of Science Education), Natalya Gomez (����SM����, Earth and Planetary Sciences), Blane Harvey (����SM����, Education), Amy Janzwood (����SM����, Bieler School of Environment/Political Science) and Nik Luka (����SM����, Architecture and Urban Planning)</p> Mon, 08 Jul 2024 12:50:46 +0000 admin 8438 at /mssi /mssi/channels/news/mcgill-spinoff-fex-energy-receives-major-grant-axelys-358220 <p><i>Company technology leverages high energy density of iron to provide carbon-free, stable renewable energy that is environmentally safe and highly dispatchable</i></p> Mon, 05 Aug 2024 18:43:00 +0000 admin 8436 at /mssi /mssi/channels/news/d2r-welcomes-rna-and-genomic-researchers-universite-de-sherbrooke-360795 <h3><b>D2R welcomes RNA and genomic researchers to Université de Sherbrooke</b></h3> <p>Montreal – October 31, 2024 – ����SM����’s DNA to RNA (D2R) research initiative is proud to announce the appointment of three new researchers at Université de Sherbrooke, marking the inaugural recipients of the D2R’s New Faculty Start-Up funding program. Université de Sherbrooke is a partner institution in the D2R initiative, working collaboratively to advance genomic and RNA research.</p> Thu, 31 Oct 2024 12:09:27 +0000 admin 8432 at /mssi /mssi/channels/news/philippe-gros-appointed-chief-scientific-officer-d2r-360796 <h3>Philippe Gros appointed Chief Scientific Officer of D2R</h3> <p>Philippe Gros has been appointed Chief Scientific Officer (CSO) of ����SM����’s DNA to RNA (D2R) Initiative, effective September 30, 2024. Prior to this role, he served as Deputy Vice-President (Research and Innovation) at ����SM����. This appointment follows a thorough international search, with the selection committee enthusiastic about their recommendation. Notably, Gros was instrumental in writing the application for the D2R Initiative, laying the groundwork for its success.</p> Thu, 31 Oct 2024 12:20:11 +0000 admin 8430 at /mssi /mssi/channels/news/gene-therapy-project-receives-major-funding-360635 <h2><b>$1.14 million from CIHR will resolve treatment roadblocks for rare brain disorders</b></h2> <p> </p> <p>Gene therapy for rare neurological disorders will move one step forward thanks to a $1.14 million grant from the Canadian Institutes of Health Research (CIHR).</p> Wed, 23 Oct 2024 14:20:38 +0000 admin 8428 at /mssi /mssi/channels/news/research-new-stem-cell-models-receives-26-million-360436 <h2><b>Thomas Durcan’s project will </b><b>dissect the role of microglia in degenerative conditions, to identify new therapeutic strategies for Alzheimer's treatment</b></h2> <p>An innovative new program based at The Neuro has received $2.6 million from the CQDM and the Brain Canada Foundation.</p> Wed, 16 Oct 2024 14:44:26 +0000 admin 8421 at /mssi